NCT05192122View on ClinicalTrials.gov

Free from Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2021

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Multiple Myeloma
Interventions
OTHER

Discontinue maintenance therapy SOC

Continue maintenance therapy SOC

Trial Locations (1)

60612

RECRUITING

University of Illinois Cancer Center, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER